Through the MRCF, we have created an ecosystem that supports portfolio companies and personnel at all stages of the development cycle.
In addition to the support and resources Brandon Capital provides, we also ensure integration amongst portfolio companies so they’re able to provide support and counsel to one another while progressing through the commercialisation process.
An early-stage fund dedicated to supporting the development and commercialisation of early-stage medical technologies.
Access to risk-tolerant and patient investment capital to support the development of promising technologies.
Through our due diligence process, we apply resources to help inform and guide the development of your assets.
Through the MRCF, you also have access to the resources and capabilities of more than 50 medical research organisations and hospitals across Australia and New Zealand.
Funding comes from some of Australia’s largest and most successful superannuation funds, ensuring that your products have access to sufficient capital to ensure their continued development.